# Auris Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/auris-health

- Industry: Medical Devices & Equipment
- Headquarters: Redwood City, US
- Website: www.aurishealth.com
- Total disclosed funding: $720M
- Latest round: Series D (Nov 13, 2018)
- Investors on record: 13

## About

Based in California, US, and founded in 2007 by Frederic Moll, Auris Health, Inc., f.k.a. Auris Surgical Robotics, Inc. provides Monarch Platform, a technology that uses the power of robotics for diagnostic and therapeutic bronchoscopic procedures. In November 2018, Auris Health, Inc. raised USD 204.78 million in a Series D funding led by Partner Fund Management, with participation from Wellington Management, D1 Capital Partners, Senator Investment Group, and E15 VC, Mithril Capital, Lux Capital, and Viking Global Investors. In February 2019, Ethicon, Inc. a subsidiary of Johnson & Johnson agreed to acquire Auris Health, Inc. for approximately USD 3.4 billion in cash, with an additional USD 2.35 billion in contingent milestone payments. The acquisition was completed in April 2019.

Auris Health, Inc. provides Monarch, a robotic platform technology that provides physicians with precise instrument control, computed guidance, and continuous bronchoscope vision throughout the entire procedure. The company’s platform is integrated with robotics, micro-instrumentation, endoscope design, sensing, and data science to enhance physician capabilities, create new categories of care, and evolve minimally invasive techniques to offer optimal patient outcomes. In addition, the company provides an online portal for patients to find physicians and hospitals.

## Funding rounds

- Series D, Nov 13, 2018, $205M — Wellington Management, Viking Global Investors, Lux Capital, Mithril, Partner Fund Management, Senator Investment Group, E15 VC, D1 Capital Partners
- Series D, Apr 4, 2017, $280M — Viking Global Investors, Lux Capital, Coatue Management, Mithril, Partner Fund Management, Highland Capital Partners, Section 32
- Series C, Jul 27, 2016, $49M — Insight Equity
- Series C, Sep 8, 2015, $150M — Lux Capital, NaviMed Capital, Mithril
- Series B, Mar 24, 2014, $34M — Highland Capital Partners, Lux Capital, NaviMed Capital, Mithril
- Series A, Jun 3, 2011, $1.9M — Highland Capital Partners

## Investors

- Highland Capital Partners (https://capitalatlas.ai/funds/highland-capital-partners) — Series A, Series B, Series D
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Series B, Series C, Series D
- NaviMed Capital (https://capitalatlas.ai/funds/navimed-capital) — Series B, Series C
- Mithril (https://capitalatlas.ai/funds/mithril) — Series B, Series C, Series D
- Insight Equity (https://capitalatlas.ai/funds/insight-equity) — Series C
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series D
- Coatue Management (https://capitalatlas.ai/funds/coatue-management) — Series D
- Partner Fund Management — Series D
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series D
- Wellington Management (https://capitalatlas.ai/funds/wellington-management) — Series D
- Senator Investment Group (https://capitalatlas.ai/funds/senator-investment-group) — Series D
- E15 VC (https://capitalatlas.ai/funds/e15-vc) — Series D
- D1 Capital Partners (https://capitalatlas.ai/funds/d1-capital-partners) — Series D